FDA Approval Activities for this Drug…

Trileptal (oxcarbazepine) Tablets, Novartis Pharmaceutical NDA 21-014/S-003 8/7/03 8/15/03 Trileptal (oxcarbazepine) Tablets and Suspension, Novartis Pharmaceutical NDA 21-014/S-007 & 21-285/S-004 Trileptal (Oxcarbazepine) Tablets & Suspension, Novartis NDA 21-014/S6 & 21-285/S2 4/1/02 4/8/02 Trileptal (oxcarbazepine) Tablets, Novartis NDA 21-014/S3 8/7/03 8/15/03 Trileptal (oxcarbazepine) Tablets, Novartis NDA 21-014 1/10/99 1/19/00 1/19/00 2/28/02 Trileptal (oxcarbazepine) Tablets and Suspension, Novartis NDA 21-014/S-007 & 21-285/S-004 | Triletpal (oxcarbazepine) Tablets, Novartis Pharma, Labeling Revision | Triletpal (oxcarbazepine) Oral Solution, Novartis Pharma, Labeling Revision

For the latest approval information, please locate this drug using this index.